Cargando…
Computer-Guided Design, Synthesis, and Protein Kinase C Affinity of a New Salicylate-Based Class of Bryostatin Analogs
[Image: see text] Bryostatin 1 is in clinical trials for the treatment of cancer and Alzheimer’s disease and is a candidate for a first-in-class approach to HIV/AIDS eradication. It is neither readily available nor optimally suited for clinical use. Using a function oriented synthesis strategy, a ne...
Autores principales: | Wender, Paul A., Nakagawa, Yu, Near, Katherine E., Staveness, Daryl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334246/ https://www.ncbi.nlm.nih.gov/pubmed/25238583 http://dx.doi.org/10.1021/ol502491f |
Ejemplares similares
-
Improved Protein Kinase C Affinity through Final Step
Diversification of a Simplified Salicylate-Derived Bryostatin Analog
Scaffold
por: Wender, Paul A., et al.
Publicado: (2014) -
Simplified Bryostatin Analogues Protect Cells from
Chikungunya Virus-Induced Cell Death
por: Staveness, Daryl, et al.
Publicado: (2016) -
Bryostatin analog: improving on Nature's design
por: Boger, Dale
Publicado: (2012) -
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
por: Marsden, Matthew D., et al.
Publicado: (2018) -
In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication
por: Marsden, Matthew D., et al.
Publicado: (2017)